← Eichor
Study identifier: NCT05797454 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Efficacy and Accuracy of Combined Localization Versus Single Localization in Non-palpable Breast Cancer

Condition: Breast Cancer · Breast-conserving Surgery  ·  Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

PhaseNA
Planned participants170
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

The standard method for localizing non-palpable breast cancer is currently preoperative wire-guided localization, its positive margin rate still remains around 20-50%. This study aims to compare the accuracy and efficacy of wire vs. combined breast tissue markers in localizing non-palpable breast cancer.

This description comes directly from the study's public registry record.

Talk to the study team

Chang Gong, doctor  ·  02034070499  ·  changgong282@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityGuangzhou, Guangdong, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05797454